基于(关键地区、市场参与者、规模和份额)的制药流体处理市场 - 到 2031 年的预测

  • Report Code : TIPRE00029767
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 278
Buy Now

制药流体处理市场预计将从 2021 年的 103.0278 亿美元增至 2028 年的 142.094 亿美元;预计 2022 年至 2028 年复合年增长率为 4.7%。

制药流体处理是制药行业不可或缺的一部分,以确保止咳糖浆、静脉注射产品和复杂活性药物成分等流体安全及时地交付。为了成功和可靠,企业需要使用正确的搬运设备和仪器。生物技术和制药行业的制造部门需要流体控制系统,因为大多数流程涉及液体,例如进料介质、缓冲溶液、细胞提取物和产品馏分。

制药流体处理市场根据以下因素进行细分:产品、管道、应用、用途、最终用户和地理位置。按地域划分,市场大致分为北美、欧洲、亚太地区、中东和中东地区。非洲、南美和非洲中美洲。该报告提供了对市场的见解和深入分析,强调市场趋势、技术进步和市场动态等参数,以及对全球领先市场参与者的竞争格局的分析。

战略洞察

制药流体处理市场利润丰厚的区域

市场洞察

一次性系统采用率上升( SUS)在制药行业

在制药和生物制药产品制造中,污染预防是该过程的关键部分。正确处理和储存液体对于限制污染的可能性至关重要。设施布局有助于确定公司处理流体传输和存储的方法。一次性系统 (SUS) 的日益普及减少了产品交叉污染,消除了批次之间的清洁需求,从而提高了效率。 SUS 在洁净室中制造;它们采用双袋包装,并使用伽玛、环氧乙烷或 X 射线方法来确保每批次的无菌系统。

在疫苗、单克隆抗体和个性化抗体等多种医药产品的开发过程中在药品中,使用 SUS 是因为它提供更快、更简单且更便宜的制造工艺。由于慢性病患病率不断上升,对有效药物和产品的需求不断增长。因此,越来越多的公司选择 SUS,因为它可以提高流程效率并降低与清洁、灭菌和维护相关的成本。此外,低污染风险和低耗水量是支持制药流体处理市场增长的几个因素。市场增长还归因于公司活动的增加以及各种业务策略的快速采用,例如协作、伙伴关系和产品发布。例如,2022年4月,默克与无锡国家高新技术产业开发区签署协议,扩建其亚太地区首个莫比乌斯一次性制造中心。

因此,不锈钢在生产中的使用增加无菌液体的传输和传输正在推动制药液体处理市场的增长。

疫苗产量增加

疫苗可以增强不同年龄组的免疫系统,提供针对传染病的保护。在过去的几十年里,有效的免疫接种消除了死亡率很高的脊髓灰质炎和天花。近年来,由于病毒和细菌传染病发病率上升,疫苗接种需求不断增加。此外,政府基金会、医院和制药公司正致力于通过在全球范围内提供具有成本效益的免疫接种来定期接种疫苗。这增加了疫苗生产的需求,这可能会促进制药流体处理市场的增长。例如,印度全民免疫计划 (UPI) 向 210 万名儿童推出了肺炎球菌结合疫苗。此外,政府资助和公司投资正在刺激研发以推出新产品。据世界卫生组织统计,2022年11月,2021年共供应了160亿剂疫苗,价值1410亿美元,大约是2019年供应量58亿剂的三倍。印度血清研究所(SII)因专注于 COVID-19 疫苗的开发,将 HPV 疫苗生产推迟两年;不过,它将在 2023 年之前开始向印度政府小批量供应 HPV 疫苗。因此,预计疫苗产量的增加将在预测期内为制药流体处理市场创造机会。

基于管道的见解

基于管道,全球制药流体处理市场分为热塑性弹性体(TPE)、聚氯乙烯(PVC)和硅胶。 2022年,有机硅细分市场占据最大市场份额。 TPE 领域预计将在 2022 年至 2028 年期间以最高复合年增长率增长。热塑性弹性体 (TPE) 具有出色的加工性能,适用于所有传统的挤出设备和注塑成型。它们具有成本效益、排放量低和可靠的可重复使用性。高质量、专业的管道对于设计高效的药物流体处理系统至关重要;预灭菌管材需要满足特定的制造标准,并且当管材暴露于高压灭菌、气体处理、伽马射线照射和其他灭菌方法时,需要具有灭菌能力。生物制药管材的一个重要考虑因素是其焊接和密封能力; TPE 可焊接和热封。例如,2022年5月18日,医疗和制药设备制造商Freudenberg Medical推出了HelixFlex,它结合了所有优点,即可焊接、半透明、可密封,并且可用于蠕动泵应用。高纯度热塑性弹性体 TPE 管材专为生物制药和制药应用而设计。

基于应用的见解

根据应用,制药流体处理市场分为流体处理和流体处理。管理、液体制备、集成和自动化、无菌处理、缓冲管理等。流体处理和2021年,管理细分市场占据最大市场份额;然而,集成和预计到 2028 年,自动化领域将成为市场最大的股东。自动化是不可避免的,而且会不断扩展。随着技术的不断进步,自动化显示出改变流程和提高性能的潜力。在制药行业,自动化的使用还可以通过其持续执行重复任务的能力来减少人为错误的可能性。制药公司一直在将自动化集成到药物开发、序列化和防伪等特定流程中。在制造示例中,自动化在流体处理和管理等过程中已变得普遍。自动化对于体外诊断 (IVD)、分子分析、流式细胞术、下一代测序 (NGS) 或细胞生物学系统至关重要。此外,将混合技术与过滤和流体管理相结合,可以使用标准配方自动制备流体,以混合、调节 pH 值和过滤工艺缓冲液。因此,对自动化设备不断增长的需求预计将在未来几年推动制药流体处理市场的发展。

制药流体处理市场,由 Tubing – 2021 年和 2028 年

产品发布和并购是全球制药流体处理市场参与者广泛采用的策略。下面列出了最近的一些关键产品开发:

  • 2022 年 10 月,领先的科技公司默克为其新的 Millipore 开设了商业设施CTDMO 在法国 Martillac 公司所在地提供服务。
  • 2022 年 7 月,总部位于爱沙尼亚首都塔林的 A&G AS 自 2021 年起成为 Raumedic 公司集团的一部分。该公司专注于医疗技术领域的组装,并配备了相应的洁净室生产空间。

COVID-19大流行扰乱了全球人民和企业的日常生活以及药品供应链条受到很大影响。 COVID-19 大流行给医疗保健基础设施带来了巨大压力,并阻碍了生物制药公司和临床实验室的运营能力。 COVID-19 大流行导致行业增长显着,因为药物液体处理的需求很高,因为必须在实验室更快地处理标本才能对 COVID-19 病毒进行研究。 COVID-19 疫苗的开发增加了对先进自动化液体处理系统的需求。由于 COVID-19 的爆发,市场出现了积极增长。

制药流体处理 –市场细分

根据产品种类,市场分为设备和设备。解决方案和服务。设备及解决方案进一步细分为计量泵和胶囊设备(灌装/分选)、混合设备和阀门、热处理设备(冷却器/冷冻机/干燥器/热交换器)、X 射线检测系统、液体储罐和流量控制产品、过滤器/过滤器套件(预过滤器/灭菌级过滤器/病毒过滤器)、粉末处理袋、无菌连接器/隔离器和膜滤筒等。根据管材,市场分为 TPE、PVC 和硅胶。根据应用,市场分为流体处理和管理、流体制备、集成和自动化、无菌处理、缓冲液管理等。流体处理和管理部分进一步细分为一次性系统和多用途系统、生物处理工作站、标准存储系统和生物容器、手提袋等。根据用途,市场分为止咳糖浆、静脉注射产品、复杂原料药等。复杂的原料药部分进一步分为疫苗、癌症治疗药物等。根据最终用户,市场分为生物技术公司、制药和医疗公司等。根据地理位置,市场分为北美(美国、加拿大和墨西哥)、欧洲(法国、德国、英国、意大利、西班牙和欧洲其他地区)、亚太地区(中国、日本、印度、澳大利亚、韩国和亚太地区其他地区)、中东和美国非洲(沙特阿拉伯、南非、阿联酋以及中东和非洲其他地区)、南非和非洲中美洲(巴西、阿根廷以及南美洲和中美洲其他地区)。

公司简介

  • CIRCOR International Inc
  • Parker Hannifin Corp
  • 丹纳赫公司
  • 斯派莎克工程有限公司
  • 默克公司
  • Rochling SE & Co KG
  • RAUMEDIC AG
  • Tef Cap Industries Inc
  • Fraser Ross Ltd
  • 澳大利亚流体处理有限公司
  • ul>
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is meant by the pharmaceutical fluid handling market?

Pharmaceutical fluid handling is an integral part of pharmaceutical industry to ensure that fluids such as cough syrups, intravenous products, and complex active pharmaceutical ingredients are delivered in a safe and timely manner. To succeed and be reliable, businesses need to utilize the correct handling equipment and instruments. The manufacturing divisions in the biotechnology and pharmaceutical industry require fluid control systems since their most processes involve liquid such as feed media, buffer solutions, cell extracts, and product fractions.

What are the driving factors for the pharmaceutical fluid handling market across the globe?

Surge in drug production and rise in adoption of single-use systems (SUS) in pharmaceutical industry are the most significant factors responsible for the overall market growth.

Which segment led the pharmaceutical fluid handling market?

Based on offering segment, the equipment segment took the forefront leaders in the worldwide market by accounting largest share in 2021 and is expected to continue to do so till the forecast period.

Which usage segment held the largest market share in the pharmaceutical fluid handling market?

Based on the usage, cough syrup segment took the forefront leaders in the worldwide market by accounting largest share in 2021 and is expected to continue to do so till the forecast period.

Which end user segment held the largest market share in the pharmaceutical fluid handling market?

The biotechnology companies segment dominated the pharmaceutical fluid handling market and accounted for the largest market share in 2021.

Who are the key players in the pharmaceutical fluid handling market?

CIRCOR Internatioonal Inc., Parker Hannifin Corp, Danaher Corp, Spirax Sarco Engineering plc, Merck KGaA, Rochling SE & Co KG, RAUMEDIC AG, Tef Cap Industries Inc, Fraser Ross Ltd, Australian Fluid Handling Pty Ltd among others are among the leading companies operating in the pharmaceutical fluid handling market.

The List of Companies - Pharmaceutical Fluid Handling Market

  1. CIRCOR Internatioonal Inc
  2. Parker Hannifin Corp
  3. Danaher Corp
  4. Spirax Sarco Engineering plc
  5. Merck KGaA
  6. Rochling SE & Co KG
  7. RAUMEDIC AG
  8. Tef Cap Industries Inc
  9. Fraser Ross Ltd
  10. Australian Fluid Handling Pty Ltd

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports